Synonyms: DSP-3025
Compound class:
Synthetic organic
|
|
References |
1. Aryan Z, Rezaei N. (2015)
Toll-like receptors as targets for allergen immunotherapy. Curr Opin Allergy Clin Immunol, 15 (6): 568-74. [PMID:26418475] |
2. Biggadike K, Ahmed M, Ball DI, Coe DM, Dalmas Wilk DA, Edwards CD, Gibbon BH, Hardy CJ, Hermitage SA, Hessey JO et al.. (2016)
Discovery of 6-Amino-2-{[(1S)-1-methylbutyl]oxy}-9-[5-(1-piperidinyl)pentyl]-7,9-dihydro-8H-purin-8-one (GSK2245035), a Highly Potent and Selective Intranasal Toll-Like Receptor 7 Agonist for the Treatment of Asthma. J Med Chem, 59 (5): 1711-26. [PMID:26861551] |
3. Greiff L, Ahlström-Emanuelsson C, Alenäs M, Almqvist G, Andersson M, Cervin A, Dolata J, Lindgren S, Mårtensson A, Young B et al.. (2015)
Biological effects and clinical efficacy of a topical Toll-like receptor 7 agonist in seasonal allergic rhinitis: a parallel group controlled phase IIa study. Inflamm Res, 64 (11): 903-15. [PMID:26342289] |
4. Greiff L, Cervin A, Ahlström-Emanuelsson C, Almqvist G, Andersson M, Dolata J, Eriksson L, Högestätt E, Källén A, Norlén P et al.. (2012)
Repeated intranasal TLR7 stimulation reduces allergen responsiveness in allergic rhinitis. Respir Res, 13: 53. [PMID:22726593] |
5. Kurimoto A, Hashimoto K, Isobe Y, Brough S, Millichip I, Wada H, Bonnert R, McInally T. (2014)
9-Substituted 8-Oxoadenine Compound. Patent number: US20140045837. Assignee: Astrazeneca Aktiebolag, Dainippon Sumitomo Pharma Co., Ltd.. Priority date: 26/03/2004. Publication date: 13/02/2014. |